Impairment of Spike-Timing-Dependent Plasticity at Schaffer Collateral-CA1 Synapses in Adult APP/PS1 Mice Depends on Proximity of Aβ Plaques
Open Access
- 30 January 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (3), 1378
- https://doi.org/10.3390/ijms22031378
Abstract
Alzheimer’s disease (AD) is a multifaceted neurodegenerative disorder characterized by progressive and irreversible cognitive decline, with no disease-modifying therapy until today. Spike timing-dependent plasticity (STDP) is a Hebbian form of synaptic plasticity, and a strong candidate to underlie learning and memory at the single neuron level. Although several studies reported impaired long-term potentiation (LTP) in the hippocampus in AD mouse models, the impact of amyloid-β (Aβ) pathology on STDP in the hippocampus is not known. Using whole cell patch clamp recordings in CA1 pyramidal neurons of acute transversal hippocampal slices, we investigated timing-dependent (t-) LTP induced by STDP paradigms at Schaffer collateral (SC)-CA1 synapses in slices of 6-month-old adult APP/PS1 AD model mice. Our results show that t-LTP can be induced even in fully developed adult mice with different and even low repeat STDP paradigms. Further, adult APP/PS1 mice displayed intact t-LTP induced by 1 presynaptic EPSP paired with 4 postsynaptic APs (6× 1:4) or 1 presynaptic EPSP paired with 1 postsynaptic AP (100× 1:1) STDP paradigms when the position of Aβ plaques relative to recorded CA1 neurons in the slice were not considered. However, when Aβ plaques were live stained with the fluorescent dye methoxy-X04, we observed that in CA1 neurons with their somata 200 µm away from plaques. Treatment of APP/PS1 mice with the anti-inflammatory drug fingolimod that we previously showed to alleviate synaptic deficits in this AD mouse model did not rescue the impaired t-LTP. Our data reveal that overexpression of APP and PS1 mutations in AD model mice disrupts t-LTP in an Aβ plaque distance-dependent manner, but cannot be improved by fingolimod (FTY720) that has been shown to rescue conventional LTP in CA1 of APP/PS1 mice.Funding Information
- EU Joint Programme – Neurodegenerative Disease Research (Project No. 643417, jointly supported by BMBF and Horizon 2020)
This publication has 67 references indexed in Scilit:
- Fingolimod Phosphate Attenuates Oligomeric Amyloid β–Induced Neurotoxicity via Increased Brain-Derived Neurotrophic Factor Expression in NeuronsPLOS ONE, 2013
- The Spike-Timing Dependence of PlasticityNeuron, 2012
- Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndromeProceedings of the National Academy of Sciences of the United States of America, 2012
- The Effects of NMDA Subunit Composition on Calcium Influx and Spike Timing-Dependent Plasticity in Striatal Medium Spiny NeuronsPLoS Computational Biology, 2012
- Synaptic Signaling and Aberrant RNA Splicing in Autism Spectrum DisordersFrontiers in Synaptic Neuroscience, 2011
- Spike-timing-dependent plasticity in hippocampal CA3 neuronsJournal Of Physiology-London, 2010
- Prion protein and Aβ‐related synaptic toxicity impairmentEMBO Molecular Medicine, 2010
- Opposing effects of PSD‐93 and PSD‐95 on long‐term potentiation and spike timing‐dependent plasticityJournal Of Physiology-London, 2008
- Impaired Spine Stability Underlies Plaque-Related Spine Loss in an Alzheimer's Disease Mouse ModelThe American Journal of Pathology, 2007
- Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathologyEMBO Reports, 2006